Fan, Zhongqi

ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics. [electronic resource] - Experimental cell research Jul 2015 - 68-81 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1090-2422

10.1016/j.yexcr.2015.04.016 doi


Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Apoptosis--drug effects
Bile Duct Neoplasms--drug therapy
Bile Ducts, Intrahepatic
Biphenyl Compounds--administration & dosage
Cell Line
Cell Survival--drug effects
Cholangiocarcinoma--drug therapy
Cisplatin--administration & dosage
Drug Resistance, Neoplasm--drug effects
Dynamins
GTP Phosphohydrolases--metabolism
Humans
Membrane Proteins--metabolism
Membrane Transport Proteins--metabolism
Microtubule-Associated Proteins--metabolism
Mitochondria--metabolism
Mitochondrial Dynamics--drug effects
Mitochondrial Precursor Protein Import Complex Proteins
Mitochondrial Proteins--metabolism
Mitophagy--drug effects
Myeloid Cell Leukemia Sequence 1 Protein--biosynthesis
Nitrophenols--administration & dosage
Piperazines--administration & dosage
Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors
RNA Interference
RNA, Small Interfering--genetics
RNA-Binding Proteins--genetics
Receptors, Cell Surface--metabolism
Sulfonamides--administration & dosage
bcl-2 Homologous Antagonist-Killer Protein--biosynthesis